Cantitate/Preț
Produs

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2: Diagnosis, Therapeutic Targets, and Molecular Mechanisms

Editat de Ganji Purnachandra Nagaraju, Ramakrishna Vadde
en Limba Engleză Hardback – apr 2022
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume Two: Diagnosis, Therapeutic Targets and Molecular Mechanisms for Hepatocellular Carcinoma Progression provides comprehensive information about ongoing research and clinical data surrounding liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. The volume discusses topics such as computational approaches for identification of biomarkers, enzymes and pathways of HCC, circulating and epigenetic biomarkers, drug resistance, metabolic pathways, and small molecule-target therapies. In addition, it discusses immunotherapies, immune check point inhibitors and nanotechnology-based therapies.
This book is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.


  • Provides detailed information on traditional and novel diagnostic tools for hepatocellular carcinoma
  • Discusses promising targeted therapies, both available and in development, explaining the best option to use for specific cases
  • Brings recent findings in immunotherapies, immune checkpoint inhibitors and nanotechnology-based therapeutic approaches for treatment of HCC
Citește tot Restrânge

Preț: 74689 lei

Preț vechi: 82075 lei
-9% Nou

Puncte Express: 1120

Preț estimativ în valută:
14294 14796$ 12081£

Carte tipărită la comandă

Livrare economică 26 februarie-12 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323988070
ISBN-10: 0323988075
Pagini: 398
Dimensiuni: 191 x 235 mm
Greutate: 0.89 kg
Editura: ELSEVIER SCIENCE

Public țintă

Cancer researchers, oncologists
Medical doctors, hepathologists, graduate students

Cuprins

1. Hepatocellular carcinoma diagnosis2. Computational analysis of prognosisrelated genes in liver cancer3. Computational approaches to identify biomarkers, enzymes, and pathways of hepatocellular carcinoma4. Ribonucleic acid sequence analysis in deciphering hepatocellular carcinoma5. Hepatocarcinogenesis and the role of next-generation sequencing in liver cancer6. Liver cancer: the tumor microenvironment and associated pathways7. Metabolic pathway-based target therapy to hepatocellular carcinoma: a computational approach8. Targeting ion channels in hepatic cancer9. Tyrosine kinases: their role in hepatocellular carcinoma10. Role of transcription factors in hepatocellular carcinoma11. Modulatory act of diverse transcriptional factors in liver carcinoma12. Association of specificity protein 1 with hepatocellular carcinoma13. Promising biomarkers for liver cancer14. Molecular signaling and its role in drug resistance in hepatocellular carcinomas15. Multidrug resistance, a major obstacle in hepatocellular carcinoma treatment: challenges and future perspectives16. Proliferative signaling pathways in hepatocellular carcinoma17. Targeting angiogenesis in hepatocellular carcinoma18. Conventional and novel biomarkers for the diagnosis and prognosis of liver cancer19. Updates on the staging and treatment of hepatocellular carcinoma20. ROS-mediated pathways: potential role in hepatocellular carcinoma biology and therapy21. Dysregulated cell-signaling pathways in hepatocellular carcinoma: causes and therapeutic options22. LKB1/STK11-mediated signal transduction in hepatocellular carcinoma